We develop and commercialize technologies for site-specific drug delivery to the Central Nervous System, in particular the brain, exploiting tailored drug delivery system.
We overcome barriers by delivering therapies directly to the brain.
Brain Implant Therapeutics (BIT) Pharma was founded in November 2015 by leaders from academia and industry and is based in Graz, Austria.
BIT Pharma technology is based on proprietary manufacturing process for tailored drug release at the site of action within the central nervous system (mainly the brain).
The BIT Pharma Management Team embraces industry leading experience in preclinical and clinical development, drug delivery technologies, as well as successful experience in general management.